250 related articles for article (PubMed ID: 24120926)
1. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.
Kumar S; Podratz KC; Bakkum-Gamez JN; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Keeney GL; Thomas G; Mariani A
Gynecol Oncol; 2014 Jan; 132(1):38-43. PubMed ID: 24120926
[TBL] [Abstract][Full Text] [Related]
2. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
Multinu F; Casarin J; Cappuccio S; Keeney GL; Glaser GE; Cliby WA; Weaver AL; McGree ME; Angioni S; Faa G; Leitao MM; Abu-Rustum NR; Mariani A
Gynecol Oncol; 2019 Jul; 154(1):60-64. PubMed ID: 31126637
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
4. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
[TBL] [Abstract][Full Text] [Related]
5. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
[TBL] [Abstract][Full Text] [Related]
6. Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.
Tutkun Kilinc EC; Korkmaz V; Yalcin HR
J Obstet Gynaecol; 2022 Nov; 42(8):3725-3730. PubMed ID: 36927276
[TBL] [Abstract][Full Text] [Related]
7. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
[TBL] [Abstract][Full Text] [Related]
8. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
Kumar S; Mariani A; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Podratz KC; Dowdy SC
Gynecol Oncol; 2013 Sep; 130(3):441-5. PubMed ID: 23747331
[TBL] [Abstract][Full Text] [Related]
9. Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer.
Kim NR; So KA; Kim TJ; Lim K; Lee KH; Kim MK
J Gynecol Oncol; 2023 May; 34(3):e23. PubMed ID: 36562131
[TBL] [Abstract][Full Text] [Related]
10. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
11. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
12. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
13. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
Abu-Rustum NR; Gomez JD; Alektiar KM; Soslow RA; Hensley ML; Leitao MM; Gardner GJ; Sonoda Y; Chi DS; Barakat RR
Gynecol Oncol; 2009 Nov; 115(2):236-8. PubMed ID: 19666190
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
18. Robotic infrarenal paraaortic and pelvic nodal staging for endometrial cancer: feasibility and lymphatic complications.
Geppert B; Persson J
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1074-81. PubMed ID: 26218968
[TBL] [Abstract][Full Text] [Related]
19. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
